Results 181 to 190 of about 23,896 (206)

Benralizumab (Fasenra) for Severe Eosinophilic Asthma

JAMA, 2018
openaire   +4 more sources

Mepolizumab (Nucala) For Severe Eosinophilic Asthma.

P & T : a peer-reviewed journal for formulary management
Mepolizumab (Nucala) for severe eosinophilic asthma.
Min Sung, Choy, Deepali, Dixit, Mary Barna, Bridgeman   +2 more
openaire   +1 more source

Severe eosinophilic asthma and mepolizumab

The Lancet Respiratory Medicine, 2016
openaire   +2 more sources

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

New England Journal of Medicine, 2021
Alessandro Fiocchi, Asif H Khan, Naimish Patel   +2 more
exaly  

Role of Eosinophil Mitochondrial Function in Severe Eosinophilic Asthma

A101. LINKING BIOLOGY TO THE REAL WORLD IN ASTHMA AND ALLERGIC INFLAMMATION, 2023
J.B. Koranteng, S.L. Lai, K.L. Raby, P. Dixey, K.F. Chung, C. Michaeloudes, P.K. Bhavsar   +6 more
openaire   +1 more source

Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial

New England Journal of Medicine, 2021
David J Cousins
exaly  

Mepolizumab for severe eosinophilic asthma

Expert Review of Respiratory Medicine
Maria Kallieri, Andriana I. Papaioannou, Stelios Loukides   +2 more
openaire   +1 more source

Lysis of primed eosinophils in severe asthma

Journal of Allergy and Clinical Immunology, 2013
openaire   +2 more sources

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

New England Journal of Medicine, 2017
Parameswaran Nair, Sally E Wenzel, Klaus F Rabe   +2 more
exaly  

Severe and Difficult-to-Treat Asthma in Adults

New England Journal of Medicine, 2017
Elliot Israel, Helen K Reddel
exaly